Abstract
Purpose
To evaluate the mid-term clinical results and patient satisfaction following uterine artery embolization (UAE) in women with symptomatic fibroids.
Methods
Between August 1998 and December 2002, 135 patients had UAE for symptomatic uterine fibroids. All patients were asked to fill in a questionnaire. Questions were aimed at changes in bleeding, pain, and bulk-related symptoms. Symptoms after UAE were scored as disappeared, improved, unchanged or worsened. Adverse events were noted, such as vaginal dryness and discharge, menopausal complaints or fibroid expulsion. Patient satisfaction after UAE was assessed. Patient satisfaction of women embolized with polyvinyl alcohol (PVA) particles was compared with satisfaction of women embolized with calibrated microspheres.
Results
The questionnaire was returned by 110 of 135 women (81%) at a median time interval of 14 months following UAE. In 10 women additional embolization or hysterectomy had been performed. Of the 110 responders, 86 (78%) were satisfied with the result of UAE. The proportion of satisfied women was higher in the group embolized with calibrated microspheres than in women embolized with PVA, although this difference was not statistically significant (p = 0.053).
Conclusion
UAE in women with symptomatic uterine fibroids leads to improvement of symptoms and patient satisfaction is good in the vast majority after a median follow-up period of 14 months.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Vollenhoven BJ, Lawrence AS, Healy DL (1990) Uterine fibroids: A clinical review. Br J Obstet Gynaecol 97:285–298
Ravina J, Herbreteau D, Ciraru-Vigneron N, Bouret J, Houdart E, Aymard A, et al. (1995) Arterial embolisation to treat uterine myomata. Lancet 346:671–672
Watson GMT, Walker WJ (2002) Uterine artery embolisation for treatment of symptomatic fibroids in 114 women: Reduction of the fibroids and women’s view of the success of the treatment. Br J Obstet Gynaecol 109:129–135
Walker WJ, Pelage PJ (2002) Uterine artery embolisation for symptomatic fibroids: Clinical results in 400 women with imaging follow-up. Br J Obstet Gynaecol 109:1262–1272
Worthington-Kirsch RL, Popky GL, Hutchins FL (1998) Uterine arterial embolization for the management of leiomyomas: Quality-of-life assessment and clinical response. Radiology 208:625–629
Al Fozan H, Tulandi T (2002) Factors affecting early surgical intervention after uterine artery embolization. Obstet Gynecol 57:810–814
Joffre F, Tubiana JM, Pelage JP; Groupe FEMIC (2004) FEMIC (Fibromes Embolises aux MICrospheres calibrees): Uterine fibroid embolization using tris-acryl microspheres. A French multicenter study. Cardiovasc Intervent Radiol 27:600–606
Siskin GP, Englander M, Stainken BF, Ahn J, Dowling K, Dolen EG (2000) Embolic agents used for uterine fibroid embolization. AJR Am J Roentgenol 175:767–733
Lampmann LEH, Smeets AJ, Lohle PNM (2004) Uterine fibroids: Targeted embolization, an update on technique. Abdom Imaging 29:128–131
Hovsepian DM, Siskin GP, Bonn J, Cardella JF, Clark TW, Lampmann LE, Miller DL, Omary RA, Pelage JP, Rajan D, Schwartzberg MS, Towbin RB, Walker WJ, Sacks D (2004) Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata. Cardiovasc Intervent Radiol 27:307–313
Nikolic B, Spies JB, Lundsten M, Abbara S (2000) Patient radiation dose associated with uterine artery embolisation. Radiology 214:121–125
Nikolic B, Spies B, Abbara S, Goodwin SC (1999) Ovarian artery supply of uterine fibroids as a cause of treatment failure after uterine artery embolisation: A case report. J Vasc Interv Radiol 10:1167–1170
Pelage JP, Le Dref O, Soyer P, Kardache M, Dahan H (2000) Fibroid-related menorrhagia: Treatment with superselective embolisation of the uterine arteries and midterm follow-up. Radiology 215:428–431
Spies JB, Asher SA, Roth AR, Kim J, et al. (2001) Uterine artery embolisation for leiomyomata. Obstet Gynecol 98:29–34
Gomez-Jorge J, Keyoung A, Levy EB, Spies JB (2003) Uterine artery anatomy relevant to uterine leiomyomata embolization. Cardiovasc Intervent Radiol 26:522–527
Chrisham HB, Saker MB, Ryu RK, Nemcek AA, Gerbie MV (2000) The impact of uterine fibroid embolisation on resumption of menses and ovarian function. J Vasc Interv Radiol 11:699–703
Spies JB, Scialli AR, Jha RC, Imaoke I (1999) Initial results from uterine fibroid embolisation for symptomatic leiomyomata. J Vasc Interv Radiol 10:1149–1157
Marret H , Keris YleB, Acker O, Cottier JP, Herbreteau. (2004) Late leiomyoma expulsion after uterine artery embolization. J Vasc Interv Radiol 15:1483–1485
Berkowitz RP, Hutchins FL, Worthington-Kirsch RL (1999) Vaginal expulsion of submucosal fibroids after uterine artery embolisation. J Reprod Med 44:373–376
Spies JB, Allison S, Flick P, McCullough M, Sterbis K, Cramp M, Bruno J, Jha R (2004) Polyvinyl alcohol particles and tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: Result of a randomized comparative study. J Vasc Interv Radiol 15:793–800
Worthington-Kirsch RL (2005) Uterine artery embolization for fibroid disease is not experimental. Cardiovasc Intervent Radiol Feb 15 (Epub ahead of print)
Reekers JA (2004) Uterine artery embolization: What the others say. Cardiovasc Intervent Radiol 27:305–306
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Smeets, A.J., Lohle, P.N.M., Vervest, H.A.M. et al. Mid-term Clinical Results and Patient Satisfaction After Uterine Artery Embolization in Women with Symptomatic Uterine Fibroids. Cardiovasc Intervent Radiol 29, 188–191 (2006). https://doi.org/10.1007/s00270-005-0066-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-005-0066-4